The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency
- PMID: 9700596
- DOI: 10.1023/a:1005354624735
The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency
Abstract
We studied a 10-year-old patient with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency who was originally (mis)diagnosed as having systemic carnitine deficiency. He was subjected to a fasting test, a long-chain triglyceride (LCT) loading test (1.5 g/kg) and an intravenous carnitine clearance test (0.25 mumol/kg per min). Plasma acylcarnitines were analysed using a quantitative GC-CI-MS method. During fasting, all long-chain acylcarnitines with a chain length of C14 and higher (especially C14:1) increased dramatically. Total plasma long-chain acylcarnitine reached a concentration of 28.6 mumol/L. LCT loading resulted in a moderate increase, mainly of the C18 esters. The carnitine infusion, which led to a supranormal plasma free carnitine concentration, gave only a slight but generalized rise of long-chain acylcarnitines. Although only one patient could be tested, the results suggest that the accumulation of potentially toxic long-chain acylcarnitines in VLCAD deficiency is provoked by fasting, LCT loading and carnitine supplementation. Therapy should be adjusted accordingly.
Similar articles
-
Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.Eur J Clin Invest. 2004 Mar;34(3):191-6. doi: 10.1111/j.1365-2362.2004.01308.x. Eur J Clin Invest. 2004. PMID: 15025677
-
Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma.J Pediatr. 2016 Feb;169:208-13.e2. doi: 10.1016/j.jpeds.2015.10.045. Epub 2015 Nov 18. J Pediatr. 2016. PMID: 26602010 Free PMC article.
-
Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.Pediatr Res. 2008 Jun;63(6):632-7. doi: 10.1203/PDR.0b013e31816ff6f0. Pediatr Res. 2008. PMID: 18317232
-
Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.J Inherit Metab Dis. 2017 May;40(3):317-323. doi: 10.1007/s10545-017-0016-8. Epub 2017 Feb 28. J Inherit Metab Dis. 2017. PMID: 28247148 Review.
-
Carnitine deficiency disorders in children.Ann N Y Acad Sci. 2004 Nov;1033:42-51. doi: 10.1196/annals.1320.004. Ann N Y Acad Sci. 2004. PMID: 15591002 Review.
Cited by
-
Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.Blood. 2015 Sep 24;126(13):1595-600. doi: 10.1182/blood-2015-03-636761. Epub 2015 Jul 14. Blood. 2015. PMID: 26175037 Free PMC article.
-
Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers.Hum Mol Genet. 2019 Mar 15;28(6):928-941. doi: 10.1093/hmg/ddy403. Hum Mol Genet. 2019. PMID: 30445591 Free PMC article.
-
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.Am J Hum Genet. 1999 Feb;64(2):479-94. doi: 10.1086/302261. Am J Hum Genet. 1999. PMID: 9973285 Free PMC article.
-
Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.Res Pract Thromb Haemost. 2017 Jul;1(1):93-102. doi: 10.1002/rth2.12017. Epub 2017 Jun 20. Res Pract Thromb Haemost. 2017. PMID: 29082360 Free PMC article.
-
Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients.BMC Biol. 2023 Sep 4;21(1):184. doi: 10.1186/s12915-023-01652-9. BMC Biol. 2023. PMID: 37667308 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous